Skip to content
中文产业新闻精选评分75Chinese source

阿斯利康终止eVOLVE-Lung02三期研究，PD-1/CTLA-4双抗volrustomig对比K药一线肺癌PFS/OS难达终点

PFS/OS均难达到，AZ终止PD-1/CTLA-4双抗头对头对比K药肺癌一线3期临床试验（eVOLVE-Lung02研究）

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.